Trial | CCTA, N | UC, N | Primary end point | Outcome |
---|---|---|---|---|
CT-stat26 | 361 | 338 | Time to diagnosis | 54% reduction |
ACRIN-PA27 | 908 | 462 | Safety* | No death or MI |
ROMICAT-228 | 501 | 499 | Length of stay In hospital | 7.6 h 25% reduction |
*Safety assessed in subgroup of patients with negative CCTA with safety defined as absence of cardiac death or MI within 30 days.
CCTA, coronary CT angiography; MI, myocardial infarction; UC, usual care.